Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$13.58
$13.27
$7.94
$19.11
$1.14B1.721.11 million shs1.29 million shs
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$72.82
$62.51
$18.70
$80.00
$716.69M0.67175,658 shs176,494 shs
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
$2.28
$2.63
$0.62
$4.31
$289.74M0.75396,128 shs475,526 shs
Transcat, Inc. stock logo
TRNS
Transcat
$92.88
$81.27
$50.23
$94.76
$867.56M0.71199,421 shs170,714 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
0.00%+4.22%+6.26%+2.78%+52.24%
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
0.00%-3.27%+21.59%+80.34%+233.88%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
0.00%+1.79%-10.24%-24.75%+222.03%
Transcat, Inc. stock logo
TRNS
Transcat
0.00%+1.78%+31.19%+32.29%+14.54%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$13.58
$13.27
$7.94
$19.11
$1.14B1.721.11 million shs1.29 million shs
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$72.82
$62.51
$18.70
$80.00
$716.69M0.67175,658 shs176,494 shs
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
$2.28
$2.63
$0.62
$4.31
$289.74M0.75396,128 shs475,526 shs
Transcat, Inc. stock logo
TRNS
Transcat
$92.88
$81.27
$50.23
$94.76
$867.56M0.71199,421 shs170,714 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
0.00%+4.22%+6.26%+2.78%+52.24%
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
0.00%-3.27%+21.59%+80.34%+233.88%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
0.00%+1.79%-10.24%-24.75%+222.03%
Transcat, Inc. stock logo
TRNS
Transcat
0.00%+1.78%+31.19%+32.29%+14.54%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3.00
Buy$31.80134.17% Upside
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
3.00
Buy$43.67-40.03% Downside
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
2.00
Hold$4.0075.44% Upside
Transcat, Inc. stock logo
TRNS
Transcat
2.60
Moderate Buy$105.3313.41% Upside

Current Analyst Ratings Breakdown

Latest NAUT, EYPT, TRNS, and FEIM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/15/2026
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
Reiterated RatingHold (C+)
5/28/2026
Transcat, Inc. stock logo
TRNS
Transcat
UpgradeSell (D)Sell (D+)
5/15/2026
Transcat, Inc. stock logo
TRNS
Transcat
UpgradeStrong SellHold
5/7/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Lower Price TargetOutperform$39.00 ➝ $37.00
5/5/2026
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
UpgradeHoldStrong-Buy
5/4/2026
Transcat, Inc. stock logo
TRNS
Transcat
Reiterated RatingSell (D)
4/21/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Reiterated RatingSell (D-)
4/21/2026
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
Reiterated RatingSell (D-)
4/6/2026
Transcat, Inc. stock logo
TRNS
Transcat
DowngradeHoldStrong Sell
(Data available from 6/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$7.61M149.54N/AN/A$3.70 per share3.67
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$69.81M10.26$2.67 per share27.25$5.75 per share12.66
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/A$1.24 per shareN/A
Transcat, Inc. stock logo
TRNS
Transcat
$331.88M2.61$4.67 per share19.89$32.21 per share2.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$231.96M-$3.50N/AN/AN/A-3,566.63%-110.54%-90.15%8/5/2026 (Estimated)
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$23.69M$0.7597.09N/AN/A10.78%12.69%7.84%7/9/2026 (Estimated)
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$59M-$0.46N/AN/AN/AN/A-35.04%-29.16%8/4/2026 (Estimated)
Transcat, Inc. stock logo
TRNS
Transcat
$5.38M$0.58160.1444.23N/A1.62%5.84%3.78%8/3/2026 (Estimated)

Latest NAUT, EYPT, TRNS, and FEIM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/9/2026Q4 2026
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$0.2650N/AN/AN/A$18.58 millionN/A
5/26/2026Q4 2026
Transcat, Inc. stock logo
TRNS
Transcat
$0.51$0.56+$0.05$0.21$89.79 million$89.33 million
5/6/2026Q1 2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.79-$0.99-$0.20-$0.99$0.35 million$0.70 million
4/28/2026Q1 2026
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$0.1450-$0.12+$0.0250-$0.12$0.25 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
N/AN/AN/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/AN/A
Transcat, Inc. stock logo
TRNS
Transcat
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
6.66
6.63
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
N/A
2.60
1.32
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/A
11.85
11.85
Transcat, Inc. stock logo
TRNS
Transcat
0.33
2.33
1.99

Institutional Ownership

CompanyInstitutional Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
58.60%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
50.71%
Transcat, Inc. stock logo
TRNS
Transcat
98.34%

Insider Ownership

CompanyInsider Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
5.13%
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
28.00%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
41.10%
Transcat, Inc. stock logo
TRNS
Transcat
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12083.84 million79.54 millionOptionable
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
2009.84 million7.09 millionNot Optionable
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
130127.08 million74.85 millionOptionable
Transcat, Inc. stock logo
TRNS
Transcat
1,4139.34 million9.08 millionOptionable

Recent News About These Companies

Transcat (NASDAQ:TRNS) Lowered to Sell Rating by Wall Street Zen
Transcat Q4 Earnings Call Highlights
Transcat Names Jaime Irick as CEO

New MarketBeat Followers Over Time

Media Sentiment Over Time

Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$13.58 0.00 (0.00%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$13.58 +0.01 (+0.04%)
As of 06/18/2026 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Frequency Electronics stock logo

Frequency Electronics NASDAQ:FEIM

$72.82 0.00 (0.00%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$72.78 -0.03 (-0.05%)
As of 06/18/2026 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Frequency Electronics, Inc., together with its subsidiaries, engages in designing, development, and manufacturing of precision time and frequency control products and components for microwave integrated circuit applications. It operates through two segments, FEI-NY and FEI-Zyfer. The FEI-NY segment offers precision time and frequency control products for communication satellites, terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military; and provides design and technical support for satellite business. FEI-Zyfer segment offers global positioning system technologies to systems and subsystems for secure communications, both government and commercial, and other locator applications; and engages in sale and support of wireline telecommunications products, including US5G. It markets its products directly and through independent sales representative organizations located in the United States, Europe, and Asia. Frequency Electronics, Inc. was founded in 1961 and is headquartered in Mitchel Field, New York.

Nautilus Biotechnology stock logo

Nautilus Biotechnology NASDAQ:NAUT

$2.28 0.00 (0.00%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$2.22 -0.05 (-2.41%)
As of 06/18/2026 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Transcat stock logo

Transcat NASDAQ:TRNS

$92.88 0.00 (0.00%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$92.98 +0.11 (+0.11%)
As of 06/18/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.